Advertisement

Picture Consultech GmbH Secure Funding with RnD Grants v7 650x100px
Document › Details

Bruker Corporation. (6/2/26). "Press Release: Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry". San Diego, CA.

Organisations Organisation Bruker Corporation (Nasdaq: BRKR)
  Group Bruker (Group)
  Organisation 2 ASMS (American Society for Mass Spectrometry)
Products Product timsMRMS mass spectrometer
  Product 2 ASMS 2026 San Diego
Persons Person Speir, Paul (Bruker 200905 VP FTMS Bruker Daltonics)
  Person 2 Williams, Nora (Bruker 202602 Marketing Director at Bruker Daltonics)
     


At ASMS, Bruker Corporation (Nasdaq: BRKR) announced the launch of the new timsMRMS system, designed to empower researchers in petroleomics, sustainable fuels and advanced energy storage. The timsMRMS is an innovative platform that combines Trapped Ion Mobility Spectrometry (TIMS) with extreme-resolution Magnetic Resonance Mass Spectrometry (MRMS), to unravel the complex molecular makeup of challenging fossil fuels and green energy materials. It accomplishes this with unparalleled mass resolution (>10M) and sub-parts-per-million mass accuracy, plus isotope fine structure identification-confirmation, which enables the most confident identification of molecular species in ultra-complex mixtures.

As the global transition to more renewable energy accelerates, researchers face the challenge of analyzing ultra-high chemical complexity. The timsMRMS offers unprecedented capabilities for two vital areas in energy technology—renewable energy and energy storage.

> Next-Gen Lithium Batteries: The timsMRMS enables ultra-high-confidence molecular characterization of electrolyte formulations, solid-electrolyte interphase (SEI) degradation, and molecular changes during charge-discharge cycles of lithium-ion batteries. This allows materials scientists to better understand and control the chemical mechanisms that dictate battery lifespan, safety, and energy density.

> Advanced Bio-oils & Biofuels: By providing ultra-high-resolution clarity into molecular formulae determination and compound classes, the timsMRMS empowers researchers to address the chemical diversity of pyrolysis and biomass-derived oils, streamlining the development of sustainable, low-carbon transportation fuels.

“Many application areas in energy research present extreme levels of chemical diversity that are incredibly challenging. This has necessitated new analytical capabilities that go beyond traditional LC-MS limits,” said Dr. Paul Speir, Senior Vice President, Global MRMS Business with Bruker. “With the timsMRMS, we are equipping energy researchers with a complete unique tool that provides greater clarity and confidence in characterizing the extreme chemical complexity of next-generation batteries and alternative fuels.”


About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)

Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.


Media Contact

Nora Williams
Bruker Daltonics Marketing Communications
T: +49 (421) 2205-2843
E: nora.williams@bruker.com

Investor Relations Contact

Joe Kostka
Director, Investor Relations
T: +1 (978) 313-5800
E: Investor.Relations@bruker.com

   
Record changed: 2026-09-02

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Bruker (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Berlin Partner HealthCapital LSR Personalized Medicine 650x300px




» top